Contemporary surgical management of HIV-associated facial lipoatrophy

被引:11
作者
Funk, E.
Bressler, F. J.
Brissett, A. E.
机构
[1] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX USA
[2] Bressler Facial Plast Surg Ctr, Houston, TX USA
关键词
D O I
10.1016/j.otohns.2006.01.005
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
OBJECTIVES: The purpose of this study is to describe our experience with facial volume restoration in 39 HIV-associated facial lipoatrophy patients, and formulate a treatment algorithm that can be utilized for these patients based on their disease severity. METHODS: Preoperative and postoperative photographs were evaluated by 2 experienced facial plastic surgeons using grading scales. The reviewers' scores were then compared and the distribution of scores was analyzed. RESULTS: Thirty-nine patients underwent malar silastic implantation. Seven patients required postoperative adjuvant filler injection. Most patients' results were rated good to excellent. There were 4 late complications. CONCLUSION: HIV-associated facial lipoatrophy is a socially disabling condition that causes noticeable disfigurement and stigmatizes the patient. We demonstrate the importance of combining a reliable grading scale with a strategic treatment algorithm that utilizes multiple modalities for volume restoration.
引用
收藏
页码:1015 / 1022
页数:8
相关论文
共 20 条
[1]
Binder William J, 2004, Arch Facial Plast Surg, V6, P394, DOI 10.1001/archfaci.6.6.394
[2]
Use of recombinant human growth hormone in HIV-associated lipodystrophy [J].
Burgess, E ;
Wanke, C .
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (01) :17-24
[3]
HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management [J].
Carr, A .
AIDS, 2003, 17 :S141-S148
[4]
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[5]
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial [J].
Carr, A ;
Workman, C ;
Carey, D ;
Rogers, G ;
Martin, A ;
Baker, D ;
Wand, H ;
Law, M ;
Samaras, K ;
Emery, S ;
Cooper, DA .
LANCET, 2004, 363 (9407) :429-438
[6]
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study [J].
Carr, A ;
Hudson, J ;
Chuah, J ;
Mallal, S ;
Law, M ;
Hoy, J ;
Doong, N ;
French, M ;
Smith, D ;
Cooper, DA .
AIDS, 2001, 15 (14) :1811-1822
[7]
Collins E, 2000, AIDS Read, V10, P546
[8]
Comite Stephen L, 2004, Dermatol Online J, V10, P2
[9]
Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy [J].
Gooderham, M ;
Solish, N .
DERMATOLOGIC SURGERY, 2005, 31 (01) :104-108
[10]
Metformin in the treatment of HIV lipodystrophy syndrome - A randomized controlled trial [J].
Hadigan, C ;
Corcoran, C ;
Basgoz, N ;
Davis, B ;
Sax, P ;
Grinspoon, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (04) :472-477